Researchers analyzed data from 4,569 patients with type 2 diabetes and relatively preserved kidney function. The study looked at several biomarkers, including TNFR1, TNFR2, and KIM-1, to see if they could predict a decline in kidney health.
The analysis found that higher levels of circulating TNFR1, TNFR2, and KIM-1 were linked to a decline in kidney function. In contrast, circulating Klotho showed an inverse relationship with kidney decline. Other markers, such as FGF-23, did not show significant links, while urinary NGAL and KIM-1 showed inconsistent results across different studies.
Because these findings are exploratory and based on a small number of studies, the results are not yet definitive. There is a lot of variation in how these tests were performed across the studies included. These markers may eventually help doctors detect kidney issues earlier, but more large-scale studies are needed to confirm these links before they can be used in routine care.
Common questions
What biomarkers showed a link to kidney decline?
The study found that circulating TNFR1, TNFR2, and KIM-1 showed a potential positive association with kidney function decline. These markers may help identify changes in kidney health for people with type 2 diabetes. However, these results are exploratory and require more testing to be certain.
Are these tests reliable for diagnosis right now?
Not yet. The findings are currently considered exploratory because the data came from a small number of studies with different testing methods. Because of this uncertainty, these markers are not yet used as standard tools for diagnosis, and you should talk to your doctor about your specific care.
What did the study find about Klotho and FGF-23?
The study found an inverse association for circulating Klotho regarding kidney function decline. For circulating FGF-23, the researchers found no significant associations. These results are preliminary and were part of a larger look at many different markers.
